GSK, R/GA studio to target consumer health, tech startups – Medical Marketing and Media

In the wake of its recent rebranding and in advance of the imminent spinoff of its consumer arm, GSK has announced a venture to support early-stage consumer health and technology companies.

Re/Wire Health Studio, a collaboration between GSK Next and R/GA Ventures, is accepting its second cohort of brands. Re/Wire is a nine-week virtual program designed to scale early-stage businesses that address issues across “oral health, women’s health and wellness and mental resilience,” per the company.

The first Re/Wire cohort last year included nine companies. They ranged from the makers of an at-home oral microbiome test to an e-commerce marketplace for menstrual well-being to a digital platform that connects women of color with culturally aware providers.

GSK VP and Head of NextNick Tate is excited by the prospect of expanding Re/Wire’s remit and utilizing GSK’s resources to support enterprising healthcare endeavors.

“This is an opportunity and a vehicle for GSK Consumer Healthcare to reach and foster a new ecosystem of entrepreneurial startups which are helping us deliver better everyday health with humanity,” he said. 

Jonathan Bradley, R/GA Ventures VP and Partner, added that Re/Wire seeks to create a path to implementation for ambitious, emerging companies and “enable a more human future.”

“The objective is not just to engage some startups and see what’s happening in the space. We designed a program that is built to add value to the individual startups and the ecosystem as a whole,” Bradley said. “We can identify real pathways to collaborate with GSK partnerships and commercial engagements.”

Looking at the evolving nature of healthcare – especially in light of the pandemic’s lingering effects – Tate said the industry is being shaped by consumer expectations and interactions with different sectors, like banking or retail. As a result, he expects more consumer demand for at-home care, higher patient expectations for convenient solutions from healthcare organizations, a more hyperlocal role played by pharmacists and technology that leads to more individualized care delivery.

Bradley and Tate said Re/Wire is seeking to boost the efforts of companies that have the potential to reimagine the healthcare space. Success will be measured, they noted, by establishing a roadmap for participating companies and securing partnerships, whether commercial in nature or around R&D or potential investments.

“The mission of the GSK and Re/Wire teams is to identify the types of companies that can build the type of platform that can then grow into other types of services and behavior change,” Bradley added. 

Leave a Reply

Your email address will not be published.